Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation and dense granule secretion in schizophrenia

J K Yao1, D P van Kammen, J Gurklis

  • 1Neurochemistry and Psychopharmacology Laboratory, Highland Drive Department of Veterans Affairs Medical Center (DVAMC), Pittsburgh, PA, USA.

Psychiatry Research
|October 1, 1994
PubMed
Summary

Schizophrenia patients exhibit altered platelet aggregation and adenosine triphosphate (ATP) release, suggesting impaired platelet function. These changes correlate with psychosis severity but not medication levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biotransformation of monoterpenols upon pre-treatment with oregano essential oil vapour alleviates downy mildew susceptibility in grapevine leaves.

Plant biology (Stuttgart, Germany)·2026
Same author

[Molluscicidal activity of the secondary metabolites from <i>Streptomyces nigrogriseolus</i> XD 2-7 against <i>Oncomelania hupensis</i> and its preliminary mechanisms of molluscicidal actions].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2022
Same author

[Activity of aromatic pyrrole-based compounds against of <i>Schistosoma japonicum</i> cercariae and acute toxicity to fish].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2022
Same author

[Effects of praziquantel isomers on the proliferation and activation of the LX-2 human hepatic stellate cell line].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2022
Same author

Use of test accuracy study design labels in NICE's diagnostic guidance.

Diagnostic and prognostic research·2019
Same author

Hybrid Oleate-Iodide Ligand Shell for Air-Stable PbSe Nanocrystals and Superstructures.

Chemistry of materials : a publication of the American Chemical Society·2019

Area of Science:

  • Neuroscience
  • Hematology
  • Psychiatry

Background:

  • Platelet function may be altered in schizophrenia.
  • Antipsychotic medications could influence platelet activity.

Purpose of the Study:

  • To investigate platelet aggregation and adenosine triphosphate (ATP) release in schizophrenic patients.
  • To compare platelet function between treated and untreated schizophrenic patients and healthy controls.
  • To explore correlations between platelet function and clinical parameters.

Main Methods:

  • Assessed platelet aggregation and ATP release in response to collagen, arachidonic acid (AA), and adenosine diphosphate (ADP).
  • Compared functional states in normal controls, haloperidol-treated schizophrenic patients, and drug-free schizophrenic patients.

Related Experiment Videos

  • Correlated platelet function with psychosis ratings, medication dosage, and illness duration.
  • Main Results:

    • Platelet aggregation was higher in both patient groups compared to controls (collagen-induced).
    • AA-induced ATP release was lower in haloperidol-treated patients versus controls.
    • ATP release was higher in drug-free patients than when they were on haloperidol.
    • Collagen-induced platelet function correlated negatively with psychosis ratings.

    Conclusions:

    • Schizophrenia is associated with distinct alterations in platelet function, including impaired ATP release.
    • Haloperidol treatment may affect platelet adenosine triphosphate (ATP) secretion.
    • Platelet dysfunction in schizophrenia correlates with psychosis severity, independent of medication dosage or illness duration.